StockNews.AI
FLGT
StockNews.AI
89 days

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc.  - FLGT

1. Pomerantz LLP investigates potential securities fraud at Fulgent Genetics. 2. Investigation follows a civil demand from the DOJ on false claims. 3. Stock price dropped 2.61% after DOJ news on February 28, 2025. 4. Investors are encouraged to contact Pomerantz for class action participation. 5. Company faces serious legal concerns that could impact shareholder value.

3m saved
Insight
Article

FAQ

Why Bearish?

The ongoing investigation and DOJ demand signal significant legal risks that could further depress stock prices, as seen historically with similar cases leading to price declines.

How important is it?

The investigation regarding potential securities fraud could profoundly affect investor confidence and the stock price, indicating high importance.

Why Short Term?

Legal proceedings typically have immediate effects on stock price sentiment, demonstrated by the recent price drop post-announcement.

Related Companies

MYGNLHDGX
NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Fulgent Genetics, Inc. (“Fulgent” or the “Company”) (NASDAQ: FLGT).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Fulgent and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] On February 28, 2025, Fulgent disclosed in its annual report, filed with the U.S. Securities and Exchange Commission, that it had received a civil investigative demand from the U.S. Department of Justice regarding potential false claims submitted under the Uninsured Program.  On this news, Fulgent’s stock price fell $0.41 per share, or 2.61%, over the following two trading sessions, to close at $15.28 per share on March 3, 2025. Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com. Attorney advertising. Prior results do not guarantee similar outcomes. CONTACT:Danielle PeytonPomerantz LLPdpeyton@pomlaw.com646-581-9980 ext. 7980

Related News